|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
CAH Panel 7 (21-Hydroxylase Deficiency Therapeutic Monitoring)
Test Code15277
CPT Codes
82157, 83498, 84403<br>**This test is not available for New York patients less than 6 years of age**
Includes
17-Hydroxyprogesterone
Androstenedione
Testosterone, Total, MS
Androstenedione
Testosterone, Total, MS
Preferred Specimen
3 mL serum collected in a red-top tube (no gel)
Patient Preparation
An early morning specimen is preferred.
Minimum Volume
0.4 mL
Other Acceptable Specimens
Plasma collected in: EDTA (royal blue-top) tube, sodium or lithium heparin (green-top) tube, sodium heparin lead-free (tan-top) tube, or PPT Potassium EDTA (white-top) tube
Instructions
Specify time of day specimen was collected, patient age and sex on test request form.
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 2 years
Refrigerated: 7 days
Frozen: 2 years
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic • Received room temperature • Serum separator tube (SST)
Methodology
Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up and Report available: See individual assays
Reference Range
See Laboratory Report
Clinical Significance
Test is recommended for steroid replacement therapy.